Clinical association of miR-155-5p with breast cancer and its relevance for treatment with PARP inhibitors

被引：0
|
作者：
Pasculli, Barbara [1 ]
Barbano, Raffaela [1 ]
Fontana, Andrea [1 ]
Biagini, Tommaso [1 ]
Di Viesti, Maria Pia [1 ]
Rendina, Michelina [1 ]
Valori, Vanna Maria [1 ]
Morritti, Maria [1 ]
Bravaccini, Sara [2 ]
Ravaioli, Sara [2 ]
Maiello, Evaristo [1 ]
Graziano, Paolo [1 ]
Murgo, Roberto [1 ]
Copetti, Massimiliano [1 ]
Mazza, Tommaso [1 ]
Fazio, Vito Michele [1 ]
Esteller, Manel [3 ,4 ,5 ,6 ]
Parrella, Paola [1 ]
机构：
[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[2] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy
[3] Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
[4] Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain
[5] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain
[6] Univ Barcelona, Barcelona, Spain
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-1422
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1422
引用
收藏
页数：2
相关论文
共 50 条
  • [41] An Overview of PARP Inhibitors for the Treatment of Breast Cancer
    Laura Cortesi
    Hope S. Rugo
    Christian Jackisch
    Targeted Oncology, 2021, 16 : 255 - 282
  • [42] Role of miR-155-5p expression and its involvement in apoptosis-related factors in thyroid follicular carcinoma
    Geng, Xiang
    Sun, Yang-Yang
    Fu, Jin-Jin
    Cao, Liang
    Li, Yuan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (04) : 660 - 665
  • [43] Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis
    Liang Chen
    Xiong Yang
    Jun Zhao
    Ming Xiong
    Raya Almaraihah
    Zhaohui Chen
    Teng Hou
    Journal of Experimental & Clinical Cancer Research, 39
  • [44] Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis
    Chen, Liang
    Yang, Xiong
    Zhao, Jun
    Xiong, Ming
    Almaraihah, Raya
    Chen, Zhaohui
    Hou, Teng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [45] The role of miR-155-5p in MSI2 induced metastasis of prolonged DEHP exposed triple-negative breast cancer cells
    Jadhao, Mahendra Gunvantrao
    Chiu, Chien Chih
    CANCER RESEARCH, 2022, 82 (04)
  • [46] Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma
    Park, Bon
    Choi, Myung Eun
    Ryu, Kyung Ju
    Park, Chaehwa
    Choi, Minki
    Yoon, Sang Eun
    Kim, Won Seog
    Kim, Hyeon Ho
    Hong, Jung Yong
    Kim, Seok Jin
    EXPERIMENTAL CELL RESEARCH, 2024, 442 (02)
  • [47] Diagnostic value of VDBP and miR-155-5p in diabetic nephropathy and the correlation with urinary microalbumin
    Bai, Xu
    Luo, Qun
    Tan, Kuibi
    Guo, Liming
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (05)
  • [48] Effects of miR-155-5p regulating SIRT1 on diabetic nephropathy in mice
    Lin, Zhimin
    Yu, Jiangshui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (04): : 1617 - 1627
  • [49] The miR-155-5p/FBXO11 axis inhibits the progression of gastric cancer via the mTOR pathway
    Yuan, Tao
    Liu, Haiyan
    Li, Fangfang
    Meng, Qingyue
    Wang, Yajuan
    Yuan, Mei
    TRANSLATIONAL CANCER RESEARCH, 2025, 14 (02) : 1375 - 1387
  • [50] MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer
    Wang, Fang
    Shan, Shu
    Huo, Yan
    Xie, Zipeng
    Fang, Yehong
    Qi, Zhiying
    Chen, Fengzhen
    Li, Yongmei
    Sun, Bei
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 99 : 91 - 99
12345